Sunday 11 October 2026 Export all NVO data to Excel Powerpack

Novo Nordisk A/S

NVO Healthcare Drug Manufacturers General

Novo Nordisk A/S’s revenue for fiscal 2025 (year ended December 2025) was $46.8 billion, up 11.1% from fiscal 2024. In the quarter to June 2026, revenue grew 4.47%, EPS fell 18.7%, free cash flow grew 71.6% and total debt rose 44.4%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for five.

38.64 0.46 +1.20%

Follow NVO

Alert me

Market cap: $127.8B
P/E: 9.4×
Fwd P/E: —
Dividend yield: 4.65%
F-score: 5/9
Altman Z: 4.32
Beneish M: −2.51
Dividend safety: 46/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	68.91%	61.81%	74.07%	60.84%
Piotroski F-Score Full definition →		4	5	5	5
ROA Full definition →		22.03%	20.71%	24.29%	22.00%
ROIC Full definition →		33.99%	27.38%	28.59%	28.67%
Return on Tangible Assets Full definition →		69.35%	62.02%	70.54%	58.25%
Average Days of Receivables Full definition →		113.04	105.33	112.52	119.76
Free Cash Flow per Share Full definition →		2.12	0.99	1.10	1.72
Free Cash Flow Full definition →		9,416.60	4,388.93	4,863.47	7,610.53
Capital Expenditures Full definition →		(9,564.48)	(13,643.11)	(13,470.33)	(12,814.25)
Other line items
Cash ROIC Full definition →		19.20%	8.08%	8.28%	11.92%
Accounts Receivable Turnover Full definition →		3.57	3.58	3.65	3.44
Accounts Payable Turnover Full definition →		2.31	2.48	3.63	3.02
Inventory Turnover Full definition →		1.30	1.32	1.31	1.33
Average Days of Payables Full definition →		161.91	122.67	91.86	83.55
Days of Inventory on Hand Full definition →		321.75	308.10	318.66	294.06
Tax Rate Full definition →		(0.21)	(0.22)	(0.22)	(0.22)
Research and Development Expense of Revenue Full definition →		16.33%	16.84%	15.77%	17.54%
Selling, General and Administrative Expense of Revenue Full definition →		23.22%	22.74%	20.49%	19.64%
Share Based Compensation of Revenue Full definition →		0.00%	1.96%	0.00%	0.00%
Interest Coverage Full definition →		11.73	18.83	27.52	69.27
Operating CF/Net income Full definition →		1.24	1.16	0.96	1.12
Depreciation/Fixed assets Full definition →		0.11	0.11	0.10	0.12
Capex/Depreciation Full definition →		(2.91)	(4.10)	(4.03)	(3.08)
Revenue per Share Full definition →		10.51	10.53	11.47	11.60
Operating CF per Share Full definition →		4.27	4.06	4.13	4.60
Capex per Share Full definition →		(2.15)	(3.07)	(3.03)	(2.89)
Capex to Sales Full definition →		0.20	0.29	0.26	0.25

Show all line items

Columns are period end dates

Stockrow Weekly